Raymond L. Comenzo, MD, Tufts Medical Center
Advertisement
Articles by Raymond L. Comenzo, MD, Tufts Medical Center
Advertisement
Latest Updated Articles
Rapid Readouts: Results from the Phase 3 ANDROMEDA StudyPublished: January 14th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5